Arkolith/Insider Trading/INDP/Form 4

Linscott Walt Addison

Chief Business OfficerIndaptus Therapeutics, Inc. (INDP) · full profile →Form 4 · filed Sep 9, 2022
Net Buying
Open-Market Buys
$393
Open-Market Sells
$0
Net Open-Market Flow
$393
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 7, 2022Buy(P)150$2.62$393150

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-22-025450) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML